Fermentas International
1975
FOUNDED
M&A
STATUS
401-500
EMPLOYEES
M&A
LATEST DEAL TYPE
2
FINANCING ROUNDS
Description
Manufacturer of molecular biological products. The company offers restriction enzymes, DNA/RNA modifying enzymes, restriction enzymes, molecular cloning, nucleic acid purification, molecular labeling and detection, RNA and DNA electrophoresis products, nucleotides and primers, transfection reagents, and reagents.
Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
Primary Office
- 830 Harrington Court
- Burlington, Ontario L7N 3N4
- Canada
+1 (905) 000-0000
Fermentas International Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Fermentas International‘s full profile, request access.
Request full access to PitchBookFermentas International Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Fermentas International‘s full profile, request access.
Request full access to PitchBookFermentas International Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Viktoras Butkus Ph.D | Chairman & Chief Executive Officer | ||
| Gerhard Gerber Ph.D | President |
Fermentas International Board Members (4)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 00000000 000000 00.0 | Fermentas International | Chairman & Chief Executive Officer | 000 0000 |
3 Former Board Members
You’re viewing 1 of 4 board members. Get the full list »